We found 11 online brokers that are appropriate for Trading Cannabis Stocks Investment Platforms.

I see cannabis stocks as a sector where the gap between industry growth and shareholder returns can be surprisingly wide. Legal cannabis businesses have become more mature, but that has not automatically produced strong stock performance. I now pay much more attention to revenue, cash flow, margins, debt and dilution than I do to broad claims about the size of the cannabis market. Auxly is a useful example. It produced C$151.5 million of net revenue in 2025, up 24%, while adjusted EBITDA increased 64% to C$43.8 million. Those are the kinds of numbers I want to see before treating a cannabis company as more than a speculative trade.
I also think regulation remains one of the biggest variables. In the United States, federal cannabis policy changed materially in 2026. Certain FDA approved marijuana products were placed in Schedule III, while the broader proposal to move marijuana from Schedule I to Schedule III went through formal DEA hearing proceedings beginning on 29 June 2026. I view that as meaningful progress, but not the same thing as complete federal legalisation. State rules, federal controls, taxation, banking access and individual company exposure still matter, so I would not buy a cannabis stock simply because a regulatory headline looks positive.
When I evaluate cannabis stocks, I do not use an arbitrary market capitalisation increase such as $50,000 as a warning signal. For a publicly traded company, that figure is far too small to tell me anything useful. I look instead at percentage changes in valuation and compare them with actual business performance. For example, Auxly had a market capitalisation of roughly C$324 million on 21 August 2026, compared with about C$198 million at the end of 2025. At the same time, its trailing 12 month revenue had reached approximately C$165.6 million. That gives me actual figures with which to compare valuation and operating growth.
I also separate recreational cannabis, medical cannabis and pharmaceutical cannabis because they do not have identical economics. A company selling branded recreational products in Canada can face excise taxes, pricing pressure and intense retail competition, while a medical cannabis company selling into Germany can be affected by prescriptions, imports and local regulation. I therefore look at where each company generates its revenue rather than treating every cannabis stock as a bet on the same market.
For me, the strongest cannabis investment case is not simply that legalisation will create more buyers. I want to see whether a company can convert demand into sustainable revenue and cash. I look for improving gross margins, positive operating cash flow, manageable debt and enough cash to avoid constant share issuance. I also check how many shares are outstanding because a company can increase total revenue while repeatedly issuing shares and reducing the economic interest represented by each existing share.
As the cannabis industry matures, I think investors have to become more selective rather than simply more optimistic. Some businesses are now showing genuine operating improvement, while others are shrinking, selling assets or leaving public exchanges. That difference is why I would not describe every cannabis stock as having huge profit potential. I see the sector as a collection of very different businesses with very different levels of risk. The following 3 companies show just how wide those differences can be.
Auxly Cannabis Group is one of the cannabis businesses I can evaluate using substantial current operating data. The company sells cannabis products in Canada and has brands including Back Forty. In 2025, Auxly reported C$151.5 million in net revenue, compared with C$122.3 million in 2024. Adjusted EBITDA reached C$43.8 million, up 64%, and net income was C$41.9 million. Its gross margin on finished cannabis inventory sold improved from 46% in 2024 to 54% in 2025. I find those figures much more useful than the old description of Auxly as simply an opportunity to make money from home. It is a publicly traded operating company, not a home business scheme.
The 2026 numbers give me another useful test of that progress. During the second quarter of 2026, Auxly generated C$45.8 million in net revenue, an 18% increase from C$38.8 million in the comparable 2025 quarter. Adjusted EBITDA was C$14.3 million, up 24%, and the gross margin on finished cannabis inventory sold reached 55%. For the first 6 months of 2026, net revenue was C$85.6 million, up 20%, while adjusted EBITDA rose 40% to C$26.5 million. At 30 June 2026, Auxly reported C$38.6 million of cash and C$43.6 million of debt. I see the combination of revenue growth, positive earnings and a much stronger cash position as more important than short term movements in its share price.
I would still treat Auxly as a higher risk investment. Its results depend heavily on the Canadian cannabis market, consumer demand and its ability to protect margins. Auxly also completed a 14 for 1 share consolidation effective 28 July 2026, so I would account for that change when comparing historical share prices or per share figures. For me, the main numbers to watch through the remainder of 2026 are quarterly revenue growth, the 55% finished cannabis inventory margin, cash generation and debt.
IM Cannabis gives me a very different investment picture. It has historically focused on medical cannabis markets including Israel and Germany. In 2025, the company generated C$54.7 million in revenue, while German revenue increased more than 134% to C$36.3 million from C$15.5 million in 2024. Germany therefore accounted for more than 66% of group revenue. The company also reported C$4.7 million of positive operating cash flow for 2025. Those figures initially make the German operation stand out to me as the most important part of the 2025 story.
The picture changed sharply during 2026. For the first 6 months of 2026, IM Cannabis reported revenue of C$16.3 million, compared with C$25.2 million in the comparable 2025 period. Gross profit fell to C$2.9 million from C$6.9 million, while the company recorded an operating loss of C$3.8 million and a net loss of C$6.9 million. In the second quarter alone, revenue was C$7.6 million and the net loss reached C$4.4 million. At 30 June 2026, cash stood at only C$1.6 million against total liabilities of C$30.3 million. Those numbers make liquidity and capital structure major considerations for me.
I would also pay close attention to the strategic changes announced in August 2026. IM Cannabis announced an agreement to sell IMC Holdings and European focused assets on 17 August, followed on 18 August by its intention to complete a 30 for 1 share consolidation to support compliance with Nasdaq's minimum bid ƒ√price requirement. I see those developments as evidence that an investment thesis based mainly on the company's previous German growth needs to be reconsidered using its new structure. The company had already voluntarily delisted its shares from the Canadian Securities Exchange on 2 June 2025 while retaining its Nasdaq listing under IMCC.
Clever Leaves is the clearest example here of why I always check whether an old cannabis stock description is still current. I would not describe Clever Leaves in 2026 as a new Internet stock trading company or as a stock broker because neither description reflects what the business was. Clever Leaves operated as a medicinal cannabis company with production centred in Colombia. It previously had production operations in Portugal, but announced the wind down of those operations in 2023 as part of a restructuring that was expected to produce about $7 million in cost savings.
The company's last full year results before leaving Nasdaq also show why I would approach historical Clever Leaves investment information carefully. Fourth quarter 2023 revenue was $4.6 million, only about 5% higher than the comparable period a year earlier, and the company ended 2023 with $6.9 million in cash. Clever Leaves completed a split of shares in August 2023 because Nasdaq has a min price or you cant be listed.
The most important fact for me is that Clever Leaves voluntarily delisted its common shares and warrants from Nasdaq in May 2024. Its board cited factors including previous and likely future problems meeting Nasdaq continued listing requirements as well as the cost and administrative burden associated with public reporting. The company expected 16 May 2024 to be its final Nasdaq trading day and also moved to suspend its regular SEC reporting obligations. Because of that change, I would not present Clever Leaves alongside Auxly and IM Cannabis as though all 3 were equivalent currently exchange listed cannabis stocks. Its inclusion is more useful to me as an example of the listing, liquidity and disclosure risks that can appear in this sector.
We have conducted extensive research and analysis on over multiple data points on Cannabis Stocks to present you with a comprehensive guide that can help you find the most suitable Cannabis Stocks. Below we shortlist what we think are the best Cannabis Stocks Investment Platforms after careful consideration and evaluation. We hope this list will assist you in making an informed decision when researching Cannabis Stocks.
Selecting a reliable and reputable online Cannabis Stocks Investment Platforms trading brokerage involves assessing their track record, regulatory status, customer support, processing times, international presence, and language capabilities. Considering these factors, you can make an informed decision and trade Cannabis Stocks Investment Platforms more confidently.
Selecting the right online Cannabis Stocks Investment Platforms trading brokerage requires careful consideration of several critical factors. Here are some essential points to keep in mind:
Our team have listed brokers that match your criteria for you below. All brokerage data has been summarised into a comparison table. Scroll down.
When choosing a broker for Cannabis Stocks Investment Platforms trading, it's essential to compare the different options available to you. Our Cannabis Stocks Investment Platforms brokerage comparison table below allows you to compare several important features side by side, making it easier to make an informed choice.
By comparing these essential features, you can choose a Cannabis Stocks Investment Platforms broker that best suits your needs and preferences for Cannabis Stocks Investment Platforms. Our Cannabis Stocks Investment Platforms broker comparison table simplifies the process, allowing you to make a more informed decision.
Here are the top Cannabis Stocks Investment Platforms.
Compare Cannabis Stocks Investment Platforms brokers for min deposits, funding, used by, benefits, account types, platforms, and support levels. When searching for a Cannabis Stocks Investment Platforms broker, it's crucial to compare several factors to choose the right one for your Cannabis Stocks Investment Platforms needs. Our comparison tool allows you to compare the essential features side by side.
All brokers below are Cannabis Stocks Investment Platforms. Learn more about what they offer below.
You can scroll left and right on the comparison table below to see more Cannabis Stocks Investment Platforms that accept Cannabis Stocks Investment Platforms clients.
| Broker |
IC Markets
|
Roboforex
|
eToro
|
XTB
|
XM
|
Pepperstone
|
AvaTrade
|
FP Markets
|
SpreadEx
|
EasyMarkets
|
FXPro
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rating | |||||||||||
| Regulation | International Capital Markets Pty Ltd (Australia) (ASIC) Australian Securities & Investments Commission Licence No. 335692, Seychelles Financial Services Authority (FSA) (SD018), IC Markets (EU) Ltd (CySEC) Cyprus Securities and Exchange Commission with License No. 362/18, Capital Markets Authority(CMA) Kenya IC Markets (KE) Ltd, Securities Commission of The Bahamas (SCB) IC Markets (Bahamas) Ltd | RoboForex Ltd is authorised and regulated by the Financial Services Commission (FSC) of Belize under licence No. 000138/32, under the Securities Industry Act 2021, RoboForex Ltd is an (A category) member of The Financial Commission, also RoboForex Ltd is a participant of the Financial Commission Compensation Fund | FCA (Financial Conduct Authority) eToro (UK) Ltd (FCA reference 583263), eToro (Europe) Ltd CySEC (Cyprus Securities Exchange Commission), ASIC (Australian Securities and Investments Commission) eToro AUS Capital Limited ASIC license 491139, CySec (Cyprus Securities and Exchange Commission under the license 109/10), FSAS (Financial Services Authority Seychelles) eToro (Seychelles) Ltd license SD076, eToro (ME) Limited (ADGM) Abu Dhabi (UAE) number 220073, eToro (Europe) Ltd (AMF) Autorité des marchés financiers as a digital assets provider France | FCA (Financial Conduct Authority reference 522157) XTB Limited, CySEC (Cyprus Securities and Exchange Commission reference 169/12), DFSA (Dubai Financial Services Authority XTB MENA Limited licensed 8 July 2021), FSA (Financial Services Authority Seychelles license number SD148), FSCA (Financial Sector Conduct Authority XTB Africa (Pty) Ltd licensed 10 August 2021), KNF (Komisja Nadzoru Finansowego Polish Financial Supervision Authority) | Financial Sector Conduct Authority (FSCA) (49976) XM ZA (Pty) Ltd, Financial Services Commission (FSC) (000261/27) XM Global Limited, Cyprus Securities and Exchange Commission (CySEC) (license 120/10) Trading Point of Financial Instruments Ltd, Australian Securities and Investments Commission (ASIC) (number 443670) Trading Point of Financial Instruments Pty Ltd | Financial Conduct Authority (FCA), Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), Federal Financial Supervisory Authority (BaFin), Dubai Financial Services Authority (DFSA), Capital Markets Authority of Kenya (CMA), Pepperstone Markets Limited is incorporated in The Bahamas (number 177174 B), Licensed by the Securities Commission of The Bahamas (SCB) number SIA-F217 | Australian Securities and Investments Commission (ASIC) Ava Capital Markets Australia Pty Ltd (406684), South African Financial Sector Conduct Authority (FSCA) Ava Capital Markets Pty Ltd (45984), Financial Services Agency (Japan FSA) Ava Trade Japan K.K. (1662), Financial Futures Association of Japan (FFAJ) Ava Trade Japan K.K. (1574), Abu Dhabi Global Markets (ADGM) / Financial Regulatory Services Authority (FRSA) Ava Trade Middle East Ltd (190018), Central Bank of Ireland (C53877) AVA Trade EU Ltd, Polish Financial Supervision Authority (KNF) AVA Trade EU Ltd (branch authorisation), British Virgin Islands Financial Services Commission (BVI) Ava Trade Markets Ltd (SIBA/L/13/1049), Israel Securities Authority (ISA) ATrade Ltd (514666577), Financial Superintendence of Colombia (SFC 0261 of 2024), Investment Industry Regulatory Organization of Canada through Friedberg Direct (IIROC) | CySEC (Cyprus Securities and Exchange Commission) (371/18), ASIC AFS (Australian Securities and Investments Commission) (286354), FSP (Financial Sector Conduct Authority in South Africa) (50926), Financial Services Authority Seychelles (FSA) (SD 130) | FCA (Financial Conduct Authority) (190941), Gambling Commission (Great Britain) (8835), licence in Ireland as remote bookmaker for fixed odds betting licence number 1016176 | Easy Forex Trading Ltd is regulated by CySEC (License 079/07). This is the only entity that onboards EU clients. easyMarkets Pty Ltd is regulated by ASIC (AFS License 246566), EF Worldwide Ltd (Seychelles) is regulated by FSA (License SD056), EF Worldwide Ltd (British Virgin Islands) is regulated by FSC (License SIBA/L/20/1135), EF Worldwide (PTY) Ltd is regulated by FSCA (License 54018) | FCA (Financial Conduct Authority) (509956), CySEC (Cyprus Securities and Exchange Commission) (078/07), FSCA (Financial Sector Conduct Authority) (45052), SCB (Securities Commission of The Bahamas) (SIA-F184), FSA (Financial Services Authority of Seychelles) (SD120) |
| Min Deposit | 200 | 10 | 50 | No minimum deposit | 5 | No minimum deposit | 100 | 100 | No minimum deposit | 25 | 100 |
| Funding |
|
|
|
|
|
|
|
|
|
|
|
| Used By | 200,000+ | 730,000+ | 40,000,000+ | 2,000,000+ | 15,000,000+ | 830,000+ | 400,000+ | 200,000+ | 60,000+ | 250,000+ | 11,200,000+ |
| Benefits |
|
|
|
|
|
|
|
|
|
|
|
| Accounts |
|
|
|
|
|
|
|
|
|
|
|
| Platforms | MT5, MT4, MetaTrader WebTrader, Mobile Apps, iOS (App Store), Android (Google Play), MetaTrader iPhone/iPad, MetaTrader Android Google Play, MetaTrader Mac, cTrader, cTrader Web, cTrader iPhone/iPad, cTrader iMac, cTrader Android Google Play, cTrader Automate, cTrader Copy Trading, TradingView, Virtual Private Server, Trading Servers, MT4 Advanced Trading Tools, IC Insights, Trading Central | MT4, MT5, R Mobile Trader, R StocksTrader, WebTrader, Mobile Apps, iOS (App Store), Android (Google Play), Windows | eToro Trading App, Mobile Apps, iOS (App Store), Android (Google Play), CopyTrading, Web | MT4, Mirror Trader, Web Trader, Tablet, Mobile Apps, iOS (App Store), Android (Google Play) | MT5, MT5 WebTrader, XM Apple App for iPhone, XM App for Android Google Play, Tablet: MT5 for iPad, MT5 for Android Google Play, XM App for iPad, XM App for iOS (App Store), Android (Google Play), Mobile Apps | MT4, MT5, cTrader,WebTrader, TradingView, Windows, Mobile Apps, iOS (App Store), Android (Google Play) | MT4, MT5, Web Trading, AvaTrade App, AvaOptions, Mac Trading, AvaSocial, Mobile Apps, iOS (App Store), Android (Google Play) | MT4, MT5, TradingView, cTrader, WebTrader, Mobile Trader, Mobile Apps, iOS (App Store), Android (Google Play) | Web, Mobile Apps, iOS (App Store), Android (Google Play), iPad App, iPhone App, TradingView | easyMarkets App, Mobile Apps, iOS (App Store), Android (Google Play), Web Platform, TradingView, MT4, MT5 | MT4, MT5, cTrader, FxPro WebTrader, FxPro Mobile Apps, iOS (App Store), Android (Google Play) |
| Support |
|
|
|
|
|
|
|
|
|
|
|
| Learn More |
Sign
Up with icmarkets |
Sign
Up with roboforex |
Sign
Up with etoro |
Sign
Up with xtb |
Sign
Up with xm |
Sign
Up with pepperstone |
Sign
Up with avatrade |
Sign
Up with fpmarkets |
Sign
Up with spreadex |
Sign
Up with easymarkets |
Sign
Up with fxpro |
| Risk Warning | Losses can exceed deposits | Losses can exceed deposits | 52% of retail investor accounts lose money when trading CFDs with this provider. | 69% - 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74.48% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | 75-95 % of retail investor accounts lose money when trading CFDs | 57% of retail investor accounts lose money when trading CFDs with this provider | Losses can exceed deposits | 62% of retail CFD accounts lose money | 76% of retail investor accounts lose money when trading CFDs with this provider. | 74% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider |
| Demo |
IC Markets Demo |
Roboforex Demo |
eToro Demo |
XTB Demo |
XM Demo |
Pepperstone Demo |
AvaTrade Demo |
FP Markets Demo |
SpreadEx Demo |
easyMarkets Demo |
FxPro Demo |
| Excluded Countries | US, IR, CA, NZ, JP | AU, BE, BQ, BR, CA, CW, CZ, DE, ES, EE, EU, FM, FR, FI, GW, ID, IR, JP, LR, MP, NL, PF, PL, RU, SE, SJ, SS, SL, SI, TL, TR, DO, US, IT, AT, PT, BG, HR, CY, DK, FL, GR, IE, LV, LT, MT, RO, SK, CH | ZA, ID, IR, KP, BE, CA, JP, SY, TR, IL, BY, AL, MD, MK, RS, GN, CD, SD, SA, ZW, ET, GH, TZ, LY, UG, ZM, BW, RW, TN, SO, NA, TG, SL, LR, GM, DJ, CI, PK, BN, TW, WS, NP, SG, VI, TM, TJ, UZ, LK, TT, HT, MM, BT, MH, MV, MG, MK, KZ, GD, FJ, PT, BB, BM, BS, AG, AI, AW, AX, LB, SV, PY, HN, GT, PR, NI, VG, AN, CN, BZ, DZ, MY, KH, PH, VN, EG, MN, MO, UA, JO, KR, AO, BR, HR, GL, IS, IM, JM, FM, MC, NG, SI, | US, IN, PK, BD, NG , ID, BE, AU | US, CA, IL, IR | AF, AS, AQ, AM, AZ, BY, BE, BZ, BT, BA, BI, CM, CA, CF, TD, CG, CI, ER, GF, PF, GP, GU, GN, GW, GY, HT, VA, IR, IQ, JP, KZ, LB, LR, LY, ML, MQ, YT, MZ, MM, NZ, NI, KP, PS, PR, RE, KN, LC, VC, WS, SO, GS, KR, SS, SD, SR, SY, TJ, TN, TM, TC, US, VU, VG, EH, ES, YE, ZW, ET | BE, BR, KP, NZ, TR, US, CA, SG | US, JP, NZ | US, TR | US, IL, BC, MB, QC, ON, AF, BY, BI, KH, KY, TD, KM, CG, CU, CD, GQ, ER, FJ, GN, GW, HT, IR, IQ, LA, LY, MZ, MM, NI, KP, PW, PA, RU, SO, SS, SD, SY, TT, TM, VU, VE, YE | US, CA, IR |
You can compare Cannabis Stocks Investment Platforms ratings, min deposits what the the broker offers, funding methods, platforms, spread types, customer support options, regulation and account types side by side.
We also have an indepth Top Cannabis Stocks Investment Platforms for 2026 article further below. You can see it now by clicking here
We have listed top Cannabis Stocks Investment Platforms below.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 52% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
This communication is intended for information and educational purposes only and should not be considered investment advice or investment recommendation. Past performance is not an indication of future results.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Crypto investments are risky and may not suit retail investors; you could lose your entire investment. Understand the risks here.
Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.
Losses can exceed deposits